Class C07J : STEROIDS
Subclass 5/00: Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12247048 | Process for the preparation of cortexolone 17α-propionate and new hydrated crystalline form thereof | Mar 30, 22 | Mar 11, 25 | Farmabios S.P.A. |
| 12201640 | 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof | Dec 23, 21 | Jan 21, 25 | SAGE THERAPEUTICS, INC. |
| 12065463 | Compositions and methods for treating CNS disorders | Oct 24, 22 | Aug 20, 24 | SAGE THERAPEUTICS, INC. |
| 11986484 | 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors | Dec 19, 22 | May 21, 24 | COSMO TECHNOLOGIES LIMITED |
| 11938141 | Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives | Nov 18, 21 | Mar 26, 24 | Cassiopea S.P.A. |
| 11866459 | Cocrystal of progesterone and preparation method and use thereof | Mar 04, 21 | Jan 09, 24 | National Institutes for Food and Drug Control |
| 11833159 | Non-hormonal steroid modulators of NF-kB for treatment of disease | Oct 28, 20 | Dec 05, 23 | ReveraGen BioPharma, Inc. |
| 11780875 | Neuroactive steroids, compositions, and uses thereof | Sep 13, 21 | Oct 10, 23 | SAGE THERAPEUTICS, INC. |
| 11712443 | 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors | Apr 06, 21 | Aug 01, 23 | COSMO TECHNOLOGIES LIMITED |
| 11542297 | Compositions and methods for treating CNS disorders | Mar 15, 22 | Jan 03, 23 | SAGE THERAPEUTICS, INC. |
| 11542296 | Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders | Apr 23, 19 | Jan 03, 23 | The Texas A & M University System |
| 11530237 | Compositions and methods for treating CNS disorders | Jan 21, 20 | Dec 20, 22 | SAGE THERAPEUTICS, INC. |
| 11439652 | Ophthalmic aqueous composition | Jul 24, 20 | Sep 13, 22 | SANTEN PHARMACEUTICAL CO., LTD.; DAIICHI SANYO COMPANY, LIMITED; |
| 11376228 | Polysubstituted benzene, preparation method thereof, and method of using the same | Aug 06, 20 | Jul 05, 22 | GENIFARM LABORATORIES INC; SOUTH CHINA UNIVERSITY OF TECHNOLOGY; |
| 11344563 | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof | Jul 10, 19 | May 31, 22 | SAGE THERAPEUTICS, INC. |
| 11311512 | Lymph directing prodrugs | Aug 12, 15 | Apr 26, 22 | Monash University |
| 11280795 | Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery | May 03, 17 | Mar 22, 22 | Indiana University Research and Technology Corporation |
| 11241446 | 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof | May 31, 19 | Feb 08, 22 | SAGE THERAPEUTICS, INC. |
| 11207332 | Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivatives | Nov 18, 19 | Dec 28, 21 | Cassiopea S.P.A. |
| 11161872 | Methods for preparing bile acids | Aug 03, 18 | Nov 02, 21 | MEDYTOX INC. |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0409,576 | -ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions- | May 30, 23 | Dec 12, 24 | Oragenics, Inc |
| 2024/0368,213 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | Jun 12, 24 | Nov 07, 24 | Not available |
| 2024/0343,755 | STABLE ISOQUINOLINE-CORTICOSTEROID CONJUGATES AND USES THEREOF | Apr 29, 22 | Oct 17, 24 | Not available |
| 2024/0285,650 | NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE | Oct 27, 23 | Aug 29, 24 | Not available |
| 2024/0277,731 | 17A-MONOESTERS AND 17A,21-DIESTERS OF CORTEXOLONE FOR USE IN THE TREATMENT OF TUMORS | Mar 01, 24 | Aug 22, 24 | COSMO TECHNOLOGIES LTD. |
| 2024/0018,181 | PROCESS FOR THE PRODUCTION OF 21-(ACETYLOXY)-17-(PROPIONYLOXY)-PREGN-4-ENE-3,20-DIONE | Feb 05, 21 | Jan 18, 24 | Not available |
| 2023/0002,439 | CRYSTALLINE FORMS OF VAMOROLONE | Jun 10, 22 | Jan 05, 23 | Not available |
| 2022/0289,787 | DIMER COMBINATIONS AND USES THEREOF | Jul 24, 20 | Sep 15, 22 | Not available |
| 2022/0089,635 | CRYSTALLINE FORMS OF DEXAMETHASONE DIMERS AND USES THEREOF | Jan 31, 20 | Mar 24, 22 | Not available |
| 2021/0040,141 | 3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF | Oct 22, 20 | Feb 11, 21 | Not available |
| 2019/0083,511 | ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES | Nov 19, 18 | Mar 21, 19 | Not available |
| 2015/0376,225 | NOVEL COMPOUNDS OF 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION | Jan 23, 14 | Dec 31, 15 | SPHAERA PHARMA PVT. LTD. |
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
